文献速递神经免疫认知障碍与痴呆

EB病毒与儿童多发性硬化强相关,但与髓鞘少突胶质细胞糖蛋白抗体相关疾病无关

Epstein-Barr Virus Strongly Associates With Pediatric Multiple Sclerosis, But Not Myelin Oligodendrocyte Glycoprotein-Antibody-Associated Disease.
PubMed 文献 · Ann Neurol · 2024-02-27

研究评估了251例儿童脱髓鞘患者的病毒血清学,在血清学排除MOGAD后,MS患儿EBV感染率超过90%,而既往EBV感染与MOGAD风险无关。结果支持EBV在多发性硬化全谱中的作用,并提示MS与MOGAD病理机制不同。

要点

  • 血清学排除MOGAD后,MS患儿EBV感染率超过90%。
  • 既往EBV感染与MOGAD风险无关。
  • 研究支持EBV在MS全谱中发挥作用,MS与MOGAD机制不同。

核心结论

  • 在血清学排除MOGAD后,MS患儿EBV感染率超过90%,而既往EBV感染与MOGAD风险无关;研究支持EBV在MS全谱中的作用,并提示MS与MOGAD病理机制不同。

研究设计与样本

  • 研究纳入251例儿童期发病的脱髓鞘疾病患儿,评估病毒血清学并前瞻性确定诊断。

主要发现

  • 在血清学排除MOGAD后,MS患儿EBV感染率超过90%。
  • 既往EBV感染与MOGAD风险无关。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Reported rates of Epstein-Barr virus (EBV) seropositivity in children meeting multiple sclerosis (MS) diagnostic criteria are considerably lower than those reported in adult-onset MS, putting in question a requisite role for EBV in MS development. As prior work preceded recognition of myelin oligodendrocyte glycoprotein-associated disease (MOGAD), we assessed viral serologies in 251 children with incident demyelination and prospectively ascertained diagnoses. When MOGAD was serologically accounted for, the prevalence of EBV infection among MS children exceeded 90%, whereas remote EBV infection was not associated with MOGAD risk. Together, these findings substantiate EBV's role across the MS spectrum, and support distinct pathobiological mechanisms in MS versus MOGAD. ANN NEUROL 2024;95:700-705.

来源:Ann Neurol,查看原文。版权归原作者所有。

引用

  1. Fadda G, Yea C, O'Mahony J, et al. Epstein-Barr Virus Strongly Associates With Pediatric Multiple Sclerosis, But Not Myelin Oligodendrocyte Glycoprotein-Antibody-Associated Disease. Ann Neurol. 2024. PMID: 38411340. doi:10.1002/ana.26890

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。